|| | | | | |

Association of mutation to drug resistance

Mutation Gene Species Validation status Validation technique(s) Validation reference(s) Resistance mechanism(s) Validation score
D19E ERG3 C. albicans Validated Sterol estimation by GC-MS, R6G efflux19089303
D19E mutation reduces sterol C-5 desaturase activity, leading to sterol intermediate accumulation and decreased ergosterol, conferring resistance to FLC, AMB, and nystatin. 2